Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Transplantation | 4 | 2020 | 316 | 1.240 |
Why?
|
| Asthma | 6 | 2021 | 745 | 1.050 |
Why?
|
| Energy Metabolism | 4 | 2016 | 769 | 0.920 |
Why?
|
| Arginine | 4 | 2016 | 303 | 0.900 |
Why?
|
| Fungi | 2 | 2021 | 69 | 0.830 |
Why?
|
| Citrulline | 3 | 2015 | 83 | 0.830 |
Why?
|
| Transplant Recipients | 2 | 2021 | 209 | 0.770 |
Why?
|
| Burnout, Professional | 1 | 2023 | 114 | 0.750 |
Why?
|
| Allergens | 2 | 2021 | 245 | 0.740 |
Why?
|
| Nitric Oxide | 4 | 2015 | 439 | 0.710 |
Why?
|
| Tacrolimus | 1 | 2020 | 99 | 0.680 |
Why?
|
| Pleura | 1 | 2019 | 20 | 0.660 |
Why?
|
| Fibrinolysis | 1 | 2019 | 38 | 0.650 |
Why?
|
| Drug Monitoring | 1 | 2020 | 157 | 0.650 |
Why?
|
| Surgeons | 1 | 2023 | 247 | 0.640 |
Why?
|
| Pleural Effusion | 1 | 2019 | 101 | 0.610 |
Why?
|
| Immunity, Innate | 1 | 2021 | 372 | 0.600 |
Why?
|
| Catheterization | 1 | 2019 | 235 | 0.590 |
Why?
|
| Shock, Septic | 2 | 2009 | 146 | 0.580 |
Why?
|
| Drainage | 1 | 2019 | 256 | 0.580 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 596 | 0.560 |
Why?
|
| Graft Rejection | 1 | 2020 | 582 | 0.550 |
Why?
|
| Sepsis | 2 | 2013 | 477 | 0.550 |
Why?
|
| Nutritional Requirements | 1 | 2015 | 176 | 0.460 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 624 | 0.450 |
Why?
|
| Weight Gain | 1 | 2016 | 401 | 0.440 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 2838 | 0.430 |
Why?
|
| Enterocytes | 1 | 2013 | 71 | 0.410 |
Why?
|
| Glutamine | 1 | 2013 | 195 | 0.400 |
Why?
|
| Pyruvic Acid | 1 | 2011 | 36 | 0.380 |
Why?
|
| Rest | 1 | 2011 | 60 | 0.370 |
Why?
|
| Models, Biological | 1 | 2015 | 1441 | 0.340 |
Why?
|
| Tuberculosis | 1 | 2016 | 573 | 0.340 |
Why?
|
| Glucose | 2 | 2011 | 872 | 0.340 |
Why?
|
| Proteins | 2 | 2011 | 1037 | 0.310 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 274 | 0.300 |
Why?
|
| Carbon Isotopes | 3 | 2015 | 271 | 0.290 |
Why?
|
| Middle Aged | 12 | 2020 | 25994 | 0.280 |
Why?
|
| Respiration, Artificial | 1 | 2008 | 451 | 0.250 |
Why?
|
| Retrospective Studies | 9 | 2021 | 16021 | 0.250 |
Why?
|
| Leucine | 3 | 2013 | 309 | 0.250 |
Why?
|
| Female | 18 | 2021 | 65500 | 0.240 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 291 | 0.240 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2018 | 107 | 0.240 |
Why?
|
| Th2 Cells | 3 | 2021 | 187 | 0.240 |
Why?
|
| Nitrogen Isotopes | 2 | 2015 | 54 | 0.230 |
Why?
|
| Humans | 23 | 2023 | 123169 | 0.230 |
Why?
|
| Male | 15 | 2021 | 60082 | 0.230 |
Why?
|
| Depersonalization | 1 | 2023 | 8 | 0.220 |
Why?
|
| Adult | 12 | 2020 | 29062 | 0.200 |
Why?
|
| Antigens, Fungal | 1 | 2021 | 34 | 0.180 |
Why?
|
| Warfarin | 1 | 2021 | 118 | 0.170 |
Why?
|
| Lymphocytes | 1 | 2021 | 401 | 0.160 |
Why?
|
| Administration, Oral | 1 | 2021 | 670 | 0.160 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2018 | 4 | 0.150 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2018 | 9 | 0.150 |
Why?
|
| Acute Disease | 1 | 2020 | 1094 | 0.140 |
Why?
|
| Pectoralis Muscles | 1 | 2017 | 8 | 0.140 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 169 | 0.140 |
Why?
|
| Pulmonary Atelectasis | 1 | 2017 | 14 | 0.140 |
Why?
|
| Aged | 5 | 2020 | 19080 | 0.140 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2017 | 39 | 0.140 |
Why?
|
| Anticoagulants | 1 | 2021 | 581 | 0.130 |
Why?
|
| Lung | 2 | 2021 | 1475 | 0.130 |
Why?
|
| Demography | 1 | 2016 | 239 | 0.130 |
Why?
|
| Exhalation | 1 | 2015 | 10 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 353 | 0.120 |
Why?
|
| Indicator Dilution Techniques | 1 | 2015 | 24 | 0.120 |
Why?
|
| Isotopes | 1 | 2015 | 27 | 0.120 |
Why?
|
| Jamaica | 1 | 2015 | 25 | 0.120 |
Why?
|
| Ornithine | 1 | 2015 | 25 | 0.120 |
Why?
|
| Prognosis | 3 | 2019 | 4507 | 0.120 |
Why?
|
| Deuterium | 1 | 2015 | 106 | 0.120 |
Why?
|
| Spectrum Analysis | 1 | 2015 | 61 | 0.120 |
Why?
|
| Phenylalanine | 1 | 2015 | 120 | 0.120 |
Why?
|
| Meals | 1 | 2015 | 56 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2018 | 312 | 0.120 |
Why?
|
| India | 1 | 2015 | 217 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3378 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2011 | 3249 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3666 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2017 | 385 | 0.110 |
Why?
|
| Splanchnic Circulation | 1 | 2013 | 52 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5047 | 0.100 |
Why?
|
| Body Composition | 1 | 2015 | 513 | 0.100 |
Why?
|
| Radioactive Tracers | 1 | 2011 | 20 | 0.090 |
Why?
|
| Mitochondria | 1 | 2016 | 677 | 0.090 |
Why?
|
| Glycolysis | 1 | 2011 | 143 | 0.090 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2010 | 51 | 0.090 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 537 | 0.080 |
Why?
|
| Biomarkers | 3 | 2018 | 2946 | 0.080 |
Why?
|
| Breath Tests | 1 | 2010 | 179 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2011 | 863 | 0.080 |
Why?
|
| Quality of Life | 1 | 2017 | 1929 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 771 | 0.070 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 199 | 0.070 |
Why?
|
| Kinetics | 1 | 2009 | 1313 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3084 | 0.070 |
Why?
|
| Texas | 1 | 2015 | 3555 | 0.070 |
Why?
|
| Liver | 1 | 2013 | 1734 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2018 | 4489 | 0.060 |
Why?
|
| Homeostasis | 1 | 2009 | 682 | 0.060 |
Why?
|
| Algorithms | 1 | 2010 | 1592 | 0.050 |
Why?
|
| United States | 1 | 2016 | 10631 | 0.050 |
Why?
|
| Inflammation | 2 | 2018 | 1401 | 0.040 |
Why?
|
| Pregnancy | 1 | 2010 | 7148 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 6371 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 424 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 31 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2016 | 36 | 0.030 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2016 | 40 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 94 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 159 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 356 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2016 | 96 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 118 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1243 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2017 | 496 | 0.030 |
Why?
|
| Adolescent | 2 | 2010 | 19103 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1309 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2016 | 482 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 1996 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2008 | 12129 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1496 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 1608 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2106 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2025 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 2406 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 2802 | 0.020 |
Why?
|
| Pharynx | 1 | 2010 | 64 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 697 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2056 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2010 | 164 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1726 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3316 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 4706 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 4228 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 1259 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2010 | 1541 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10010 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 17494 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 2227 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 33749 | 0.010 |
Why?
|